Publications by authors named "Kelly Boroughs"
Intern Med J
January 2022
Article Synopsis
- The Pfizer/BioNtech BNT162b2 vaccine is a key part of Australia's COVID-19 vaccination effort, with a study reviewing safety data from 57,842 doses given in a dedicated clinic.
- Out of the vaccinations, 243 adverse events (0.42%) were reported, mainly related to stress, with a high return rate (90%) for second doses and minimal further reactions (87%).
- Only two cases of anaphylaxis (0.003%) were noted, indicating low adverse reaction rates, while also identifying patterns like female predominance in reactions and the link to previous allergies.
